ArticleCureus2025
The Price of Exposure: Xeroderma Pigmentosum and Skin Cancer.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xeroderma pigmentosum (XP) is a rare autosomal recessive genodermatosis characterized by a defect in the nucleotide excision repair pathway of DNA. This condition leads to extreme photosensitivity, pigmentary changes, premature aging, and increased risk of UV-induced skin and mucous membrane neoplasms. We report a case of squamous cell carcinoma in a 55-year-old female with XP. A 55-year-old female presented with a single asymptomatic skin lesion on the left cheek that had developed over the past two years. Examination revealed a well-defined, round to oval black raised nodulo-plaque, with a central adherent crust and raised superior margin. Histopathological examination revealed an invasive tumor arising from hyperplastic and dysplastic squamous epithelium with cytokeratin positivity. XP presents significant clinical challenges due to its severe photosensitivity and the associated risk of developing multiple skin cancers at a young age, which highlights the necessity for ongoing research into effective treatments and preventive strategies. Genetic counseling can play a vital role for families, enabling them to understand the implications for future generations. Increased awareness can help improve the quality of life and reduce the incidence of associated malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.